Epilepsy Research
Volume 31, Issue 2 , Pages 123-128 , July 1998

Antiepileptic effects of topiramate on amygdaloid kindling in rats

  • Kouichiro Amano

      Affiliations

    • National Epilepsy Center, Shizuoka Higashi Hospital, 886 Urushiyama, Shizuoka, 420-0953, Japan
    • Department of Neuropsychiatry, Kikuchi National Hospital, Kikuchi, Kumamoto, 861-1116, Japan
    • Corresponding Author InformationCorresponding author. Tel: +81 96 2482111; fax: +81 96 2484559.
    • ,
  • Kouichi Hamada

      Affiliations

    • National Epilepsy Center, Shizuoka Higashi Hospital, 886 Urushiyama, Shizuoka, 420-0953, Japan
    • ,
  • Kazuichi Yagi

      Affiliations

    • National Epilepsy Center, Shizuoka Higashi Hospital, 886 Urushiyama, Shizuoka, 420-0953, Japan
    • ,
  • Masakazu Seino

      Affiliations

    • National Epilepsy Center, Shizuoka Higashi Hospital, 886 Urushiyama, Shizuoka, 420-0953, Japan

Received 26 November 1997 ,Revised 23 March 1998 ,Accepted 27 March 1998.

References 

  1. Albe-Fessard, D., Stutinsky, F., Libouban, S., 1966. Atlas stereotaxique du diencephale du rat blanc. CNRS, Paris.
  2. Albertson TE, Peterson SL, Stark LG. Anticonvulsant drugs and their antagonism of kindled amygdaloid seizures in rats. Neuropharmacology. 1980;19:643–652
  3. Albertson TE, Joy RM, Stark LG. Carbamazepine: a pharmacological study in the kindling model of epilepsy. Neuropharmacology. 1984;23:1117–1123
  4. Albright PS, Burnham WM. Development of a new pharmacological seizure model: effects of anticonvulsants on cortical and amygdala-kindled seizures in the rats. Epelepsia. 1980;21:681–689
  5. Ashton D, Wauquier A. Behavioral analysis of the effects of 15 anticonvulsants in the amygdaloid kindled rat. Psychopharmacology. 1979;65:7–13
  6. Ben-menachem E, Henriksen O, Dam-Mikkelsen M, Schmidt D, Reid S. Double-blind, placebo-controlled trial of topiramate as add-on theraphy in patients with refractory partial seizures. Epilepsia. 1996;37:539–543
  7. Engel J, Wolfson L, Brown L. Anatomical correlates of electrical and behavioral events related to amygdaloid kindling. Ann. Neurol. 1978;3:538–544
  8. Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology. 1996;46:1684–1690
  9. Hamada K, Ishida S, Yagi K, Seino M. Anticonvulsive effects of zonisamide on amygdaloid kindling in rats. Neurosciences. 1990;16:407–412
  10. Hamada K, Ishida S, Yagi K, Seino M. Effects of zonisamide and acetazoramide on amygdaloid kindled seizures in rats-repeated administration. Epilepsia. 1995;36(Suppl. 3):S39
  11. Hamada K, Song HK, Ishida S, Yagi K, Seino M. Therapeutic effects of zonisamide and some conventional antiepileptic drugs on amygdaloid kindling in rats. J. Brain Sci. 1996;22:7–15
  12. Kamei C, Oka M, Masuda Y, Yoshida K, Shimizu M. Effects of 3-sulfamonylmetyl-1,2-benzisoxazole (AD 810) and some anti-epileptics on the kindled seizures in neocortex, hippocampus and amygdala in rats. Arch. Int. Pharmacodyn. 1981;249:164–176
  13. Lothman EW, Williamson JM, Vanlangham KE. Intraperitoneal phenytoin suppresses kindled responses: effects on motor and electrographic seizures. Epilepsy Res. 1991;9:11–18
  14. Maryanoff BE, Nortey SO, Gardocki JF, Shank RP, Dodgson SP. Anticonvulsant O-alkyl sulfamate. 2, 3:4,5-bis-o-(1-metyletylidene)-β-d-fructopyranose sulfamate and related compounds. J. Med. Chem. 1987;30:880–887
  15. Nakamura F, Hiyoshi T, Kudo T, Yagi K, Seino M. Anticonvulsant effect of topiramate on amygdaloid kindled seizures in cats. Jpn. J. Psychiatry Neurol. 1993;47:394–395
  16. Racine RJ. Modification of seizure activity by electrical stimulation. II, Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294
  17. Shank RP, Vaught JK, Gardocki JF, Coralie BD, Schupsky JJ, Raffa RB, et al. Topiramate: preclinical evaluation of a structurally novel anticonvulsant. Epilepsia. 1994;35:450–460
  18. Silver JM, Shin C, McNamura JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann. Neurol. 1991;29:356–363
  19. Song HK, Hamada K, Yagi K, Seino M. Effects of single and repeated administration of sulthiame on amygdaloid kindled seizures in rats. Epilepsy Res. 1997;27:81–87
  20. Suzuki, S., Nakamura, F., Nishimura, S., Yagi, K., Seino, M., 1995. Effects of topiramate on Gaba-activated currents in cultured cerebral neurons of the rat (in Japanese). Ann. Rep. Jpn Health Sci. Found 258–261.
  21. Tanabe K, Wang Y, Kimishima K. Anticonvulsant activities and properties of topiramate. J. Yonago Med. Assoc. 1991;42:330–346
  22. Wada JA. Pharmacological prophylaxis in the kindling model of epilepsy. Arch. Neurol. 1977;34:389–395
  23. Wauquier A, Zhou S. Topiramate: a potent anticonvulsant in the amygdala-kindled rat. Epilepsy Res. 1996;24:73–77
  24. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH. Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increase seizure threshold. Epilepsy Res. 1997;28:167–179
  25. Wise RA, Chinerman J. Effects of diazepam and phenobarbital on electrically induced amygdaloid seizures and seizure development. Neurology. 1974;45:355–363
  26. Yagi, K., 1996. The experience with topiramate—results of phase Study. Abstracts, In 9th Asian and Ocean Epilepsy Organization, Korea.

PII: S0920-1211(98)00021-7

Epilepsy Research
Volume 31, Issue 2 , Pages 123-128 , July 1998

Article Tools

* Image Usage & Resolution